MamaLift Plus

What MamaLift Plus Is

MamaLift Plus is a digital mental health platform developed by Curio Digital Therapeutics Inc. designed specifically for perinatal mental health, serving both pregnant and postpartum women. The company describes it as "the first digital plus human mental health system for moms," combining self-guided digital tools with access to licensed therapists who specialize in maternal mental health. MamaLift Plus is FDA-cleared, which means it has undergone regulatory review for safety and efficacy in clinical use. The platform operates as a clinical tool rather than a self-help app alone, positioning itself for people experiencing more significant symptoms who may need prescription-level intervention. Users take a brief 2-minute assessment to determine whether MamaLift (the self-guided app) or MamaLift Plus (the more intensive program) is the right fit for their needs.

What You Actually Get

MamaLift offers 2 distinct programs designed for different symptom levels. MamaLift is for pregnant women and postpartum women with mild to moderate symptoms, providing self-paced therapy and access to licensed therapists without requiring a prescription. MamaLift Plus is designed for postpartum women experiencing more significant depression and requires a prescription. Both programs include certain core features but with different levels of support and clinical intensity.

Users access daily check-ins to monitor emotional state in about two minutes per day. The platform includes progress tracking tools to spot patterns and maintain wellbeing connection. MamaLift and MamaLift Plus provide "self-paced therapy tools" grounded in cognitive behavioral therapy (CBT) and behavioral activation approaches, "designed by maternal health professionals" and evidence-based. For members eligible for therapist access, they can connect with "licensed therapists who specialize in maternal mental health" through the platform.

The platform introduces Bella, described as a "personal AI Navigation Assistant" who helps users navigate the apps by offering reminders to keep members on track with daily lessons and suggestions about which tools or learnings might be most relevant to them. The company notes that "AI is not directly used as part of your therapy" and serves only as a navigation and reminder tool. Users begin by taking a short two-minute assessment that helps the platform recommend whether they should start with MamaLift or MamaLift Plus based on their responses and specific needs. After assessment, users receive a "personalized care plan" designed to match their particular situation.

The platform is available as a downloadable app for mobile devices. The company describes its science approach as "activating emotional processing areas (like the amygdala)" and "strengthening executive function in the prefrontal cortex," with the goal of "rebuilding healthy patterns of thought and response through repetition."

What the Pages Prove

MamaLift Plus's key clinical claim is that "86% of moms achieve a meaningful improvement in depression symptoms," a statistic attributed to Businesswire and dated April 2024. The company also states that "80% of moms would recommend using MamaLift to a friend," attributed to 2020 research published in the International Journal of Environmental Research and Public Health. A third clinical finding states that "2 out of 3 cases of postpartum depression were avoided through early intervention" and notes the research was "validated across 2,500+ women over three years."

The platform is FDA-cleared, meaning it has regulatory approval as a clinical tool, though the company does not specify the FDA clearance category or date. The company states that both MamaLift and MamaLift Plus are "covered by most plans," referring to insurance coverage, but does not specify which insurance plans, which states are covered, or what the patient's out-of-pocket costs would be. The company does not publish whether coverage applies to both tiers of the program or only certain programs.

MamaLift Plus is available only for postpartum women, not during pregnancy; MamaLift is available "when pregnant or postpartum." MamaLift Plus differs from MamaLift in that it includes "additional FDA-cleared mental health program with clinical support" and requires a prescription. The company describes both programs as providing access to "licensed therapists who specialize in maternal mental health" for eligible users, though it does not specify what determines eligibility or whether all users get therapist access.

The website states that "most plans cover" the programs and mentions "insurance coverage" but provides no details about specific insurers, deductibles, copays, or out-of-pocket maximums. Users download the app to access services, but the site does not disclose what data the app collects, how user information is stored, or what privacy protections are in place beyond a link to the privacy policy.

What MamaLift Plus Does Not Say

The company does not publish specific pricing for either program. While the site states both are "covered by most plans," it does not specify which insurers participate, which states are covered by insurance, or what the out-of-pocket cost is for uninsured users or those whose plans do not cover the service. There is no published sliding-scale or income-based pricing for those unable to afford the program.

The site does not disclose what types of medications MamaLift Plus prescribes or whether it includes prescription management for all psychiatric medications or only certain classes. It does not state whether prescribing is done within the platform or through a separate provider, or how prescriptions are filled or delivered. There is no information about whether users can continue with the same therapist long-term or whether therapist assignments change.

MamaLift Plus does not publish specific information about the licensed therapists available, their credentials beyond being "licensed therapists," their specialization areas within maternal mental health, or their experience levels. The site does not disclose average wait times to see a therapist, how often users can access sessions, session duration, or whether the number of sessions is limited. There is no published information about what specific conditions the programs treat beyond depression and anxiety during pregnancy and postpartum.

The company does not state whether the platform is available outside the United States, in what languages it is available, or whether it works with non-English speakers. There are no published testimonials or outcome data specific to MamaLift Plus, though the site includes quotes from users praising the platform's support during pregnancy, postpartum, and their mental health journey.

Who It Fits and Who It Does Not

MamaLift Plus is designed for pregnant women and postpartum women (in MamaLift's case) or postpartum women only (in MamaLift Plus's case) experiencing depression and anxiety who want combination support of self-guided therapy plus licensed therapist access. It is well-suited for people who prefer or benefit from daily structure, tracking, and reminders, and for those who respond well to cognitive behavioral therapy approaches. MamaLift Plus specifically serves women who need clinical-level treatment and are willing or able to use prescription medication as part of their care. For those with employer or health insurance covering the program, costs are managed through that coverage rather than requiring out-of-pocket payment.

MamaLift and MamaLift Plus are not designed for people in crisis or experiencing acute suicidal thinking, which the site addresses by redirecting to the 988 crisis line and other emergency resources. The platform is not a substitute for hospitalization or crisis mental health services. MamaLift Plus is available only in the postpartum period, not during pregnancy alone, so pregnant women seeking treatment should use MamaLift or seek other services. People without insurance or whose insurance does not cover MamaLift face unknown out-of-pocket costs, and the site provides no information about affordability options or sliding-scale pricing. The platform is not designed for people who need care in languages other than English or who cannot use smartphone apps to access mental health support.